Now showing items 13951-13960 of 14011
Recommendation Regarding the Use of Ivermectin as a Treatment for COVID-19, 22 June 2020
A recent study reported that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells, and two preprint publications reported observational clinical studies on the apparent ...
Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020
Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, ...
Status Report - WHO Collaborating Centres in the Americas, 2020
This entry contains the Status Report of WHO Collaborating Centres in the Americas by Country and a new document with information of Collaborating Centres by Category/Program Areas of the Strategic Plan of the Pan American ...
Considerations for the Implementation and Management of Contact Tracing for Coronavirus Disease 2019 (COVID-19) in the Region of the Americas, 2 June 2020
This document is intended to complement the interim guidance by WHO on Contact tracing in the context of COVID-19. It aims to provide guidance and operational recommendations for implementing contact tracing for COVID-19 ...
Interpretation of laboratory results for COVID-19 diagnosis, 6 May 2020
Etiological confirmation of COVID-19 virus (SARS-CoV-2) infection can only be made by laboratory tests. In general, the currently available assays for COVID-19 can be classified into two groups: • The first group (virological ...
The Immunization Program in the Context of the COVID-19 Pandemic. Version 2 (24 April 2020)
Objective: Provide guidance regarding the operation of immunization programs in the context of the COVID-19 pandemic.
Infection prevention and control practices for care of patients in nontraditional settings with focus to the novel coronavirus (COVID-19). Interim recommendations, 18 May 2020
This document provides recommendations for infection prevention and control (IPC) practices to be applied during care in nontraditional setting in the context of the novel coronavirus (COVID-19). These recommendations are ...
A Checklist for COVID-2019 Pandemic Risk and Impact Management. Interim document,, 27 February 2020
On 30 January 2020, the Director-General of WHO declared the coronavirus disease 2019 (COVID‑19) outbreak a public health emergency of international concern (PHEIC) under the International Health Regulations (IHR 2005), ...
Considerations on Indigenous Peoples, Afro-Descendants, and Other Ethnic Groups during the COVID-19 Pandemic, 4 June 2020
Introduction: In March 2020, the World Health Organization (WHO) declared that the outbreak of COVID-19, the disease caused by a new coronavirus, constituted a pandemic, given the speed and scale of its transmission. The ...
Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews, 16 June 2020
Take home message thus far: • We examined 24 therapeutic options thus far; currently, there is no evidence of any important benefit from any therapeutic option (though remdesivir is revealing promise as one option based ...